James Meer
About James Meer
James Meer, 55, is Senior Vice President and Chief Accounting Officer at Elanco (ELAN). He joined Elanco in September 2018 after CFO and senior finance roles in healthcare tech and enterprise software, and earlier accounting/strategy roles at 3M (Aearo), Hillrom, Hillenbrand, and EY; he holds a bachelor’s in accounting/business (Marian University) and an MBA (Xavier University) . Company performance context: 2024 revenue was $4.439B with 3% organic constant-currency growth and adjusted EBITDA of $910M, reflecting portfolio momentum and deleveraging initiatives .
Past Roles
| Organization | Role | Years | Strategic Impact |
|---|---|---|---|
| Elanco Animal Health | SVP, Chief Accounting Officer | 2018–present | Principal accounting leadership at newly independent animal health company |
| Healthx, Inc. | Chief Financial Officer | 2017–2018 | Led finance at healthcare technology firm during scale-up phase |
| Appirio | Senior Vice President, Finance | 2014–2017 | Drove finance for IT consulting amid growth and client delivery expansion |
| Salesforce (ExactTarget) | Vice President & Corporate Controller | 2011–2014 | Led corporate controllership post-acquisition, strengthened reporting controls |
| 3M (Aearo Technologies) | Various finance/accounting/strategy roles | Prior to 2011 | Progressively responsible finance roles in industrial safety products |
| Hillrom | Various finance roles | Prior to 2011 | Finance leadership in medical technology operations |
| Hillenbrand Industries | Various finance roles | Prior to 2011 | Financial planning and corporate development exposure |
| Ernst & Young LLP | Assurance/Advisory | Prior to 2011 | Public accounting foundation in auditing and controls |
External Roles
| Organization | Role | Years | Notes |
|---|---|---|---|
| — | — | — | No external directorships or public boards disclosed for Meer |
Fixed Compensation
| Component | Terms | Date/Period | Notes |
|---|---|---|---|
| Base salary | $270,000 | September 2018 hire | As Chief Accounting Officer per 8-K |
| Target annual bonus | 26% of base salary | September 2018 | Under Elanco cash performance bonus plan |
| Sign-on bonus | $100,000 cash | September 2018 | Sign-on, paid at hire |
| Equity grant (RSUs) | $140,000 grant-date fair value | September 2018 | RSUs vest in equal installments over 2 years |
Performance Compensation
| Metric | Weighting | Target | Actual | Payout | Vesting |
|---|---|---|---|---|---|
| Not disclosed for Meer | — | — | — | — | — |
Company incentive metrics (context – NEO program):
| Metric | 2024 Threshold | 2024 Target | 2024 Actual | Corporate Bonus Multiple |
|---|---|---|---|---|
| Elanco Cash Earnings (ECE) (economic profit) | $(860)M | $(520)M | $(509)M | 103% |
| Performance Awards (Adjusted EBITDAR) | Two-year cycle | Prior-year Adjusted EBITDAR plus required return | 2023-2024 cycle paid at 90.36% avg multiple for NEOs | Pays after performance period |
Notes: Elanco’s annual cash incentive is based on year-over-year change in ECE; long-term PAs are based on Adjusted EBITDAR over a two-year period. The company removed the impact of the 2024 aqua divestiture from both ECE and PA calculations to avoid undue penalty from portfolio optimization .
Equity Ownership & Alignment
| Policy/Practice | Details | Applicability | Source |
|---|---|---|---|
| Executive stock ownership guidelines | CEO: ≥6x salary; other executive officers: ≥3x salary; hold ≥50% of vested equity until compliant | Executive officers (includes CAO role) | |
| Anti-hedging/anti-pledging | Executives and directors prohibited from hedging or pledging Elanco stock | All executives/directors | |
| Clawbacks | Required NYSE-compliant recoupment for restatements; supplemental policy for misconduct/restatements, recovery up to 3 years | Executives and senior management | |
| Deferred compensation | Ability to defer base/bonus and full-value equity; 1:1 match on deferrals into Elanco stock up to 6% of base+bonus (2-year cliff vest) | Senior management incl. executives | |
| Beneficial ownership disclosure | Proxy tables list directors/NEOs; individual CAO holdings not separately disclosed | Meer’s specific share count not disclosed in proxy |
Employment Terms
| Term | Details | Notes | Source |
|---|---|---|---|
| Employment start | September 2018 | Became principal accounting officer at IPO separation | |
| Initial appointment compensation | Base $270k; target bonus 26%; $100k sign-on; $140k RSUs (2-year vest) | Per Item 5.02 8-K at hire | |
| Employment agreements | Company states NEOs have no individual employment agreements; plan-based benefits apply | Company-level policy reference | |
| Executive Severance Plan (non-CIC) | Lump sum = 1x base + 1x target bonus for executives (CEO 2x), plus 12 months benefit contributions (CEO 24 months), and outplacement | Applies to eligible senior executives; adopted Nov 2020 | |
| Change-in-Control Plan (CIC) | Double-trigger; severance = 2 years’ base + 2x target bonus; 18 months benefit continuation; no excise tax gross-ups | NEO plan; company adopted CIC plans broadly at IPO | |
| Equity treatment on termination/CIC | CIC: RSUs/options fully vest; PAs vest at target. Non-CIC qualifying termination: pro-rata vesting per award terms | Award acceleration mechanics |
Investment Implications
- Disclosure depth: Meer is a key finance leader but not a Named Executive Officer; detailed annual pay outcomes and current beneficial ownership aren’t disclosed in proxy tables, limiting direct pay-for-performance calibration at the individual level. Monitor Section 16 Form 4 filings for any selling pressure or alignment signals going forward.
- Alignment frameworks: Strong governance mitigants—3x salary ownership guideline for executive officers, anti-hedging/anti-pledging, and robust clawbacks—support shareholder alignment and reduce red-flag risks around hedging/pledging and windfall retention .
- Incentive design signal: Company-wide incentives emphasize cash earnings (ECE) and Adjusted EBITDAR, with transparent adjustments for portfolio actions (aqua divestiture). 2024 ECE delivered a 103% corporate multiple, suggesting modest over-target performance and disciplined capital accountability—constructive for finance leadership credibility .
- Team continuity: CFO transition in July 2025 may raise near-term finance organization execution risk; continued presence of a seasoned CAO (Meer) helps continuity in disclosure controls and reporting quality during leadership change .
Best AI for Equity Research
Performance on expert-authored financial analysis tasks
Best AI for Equity Research
Performance on expert-authored financial analysis tasks